n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.

  title={n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.},
  author={Raffaele De Caterina and Rosalinda Madonna and Alessandra Bertolotto and Erik Berg Schmidt},
  journal={Diabetes care},
  volume={30 4},
The current interest for the use of n-3 (polyunsaturated) fatty acids in vascular disease can be originally tracked to observations in Greenland Inuits (Eskimos), revealing a lower prevalence of coronary heart disease (CHD) in these populations compared with Scandinavian control subjects (1–4). In a series of pioneering studies, Dyerberg and Bang (5,6) originally showed that Inuits had an attenuated platelet reactivity and a prolonged bleeding time compared with Scandinavian control subjects… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 49 extracted citations


Publications referenced by this paper.
Showing 1-10 of 175 references

Prevalence of Diabetes Mellitus With Special Reference to the Role of Under Nutrition

  • OP Gupta, SK Dave, RD Jani
  • New Delhi, J.S. Bajaj Interprint Publishers,
  • 1984
Highly Influential
8 Excerpts

The composition of food consumed by Greenland Eskimos

  • HO Bang, J Dyerberg, N Hjoorne
  • Acta Med Scand 200:69–73,
  • 1976
Highly Influential
10 Excerpts

The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia

  • EB Schmidt, SD Kristensen, R De Caterina, DR Illingworth
  • Atherosclerosis 103:107–121,
  • 1993
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…